The National Institutes of Health (NIH) is offering a grant to support the development of novel therapeutics directed towards intracellular HIV targets. This grant aims to explore the critical viral-associated proteins expressed during the HIV life cycle, focusing on developing effective strategies to achieve potent antiviral activity. The deadline for applications is July 1, 2020.
Opportunity ID: 323183
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-19-072 |
| Funding Opportunity Title: | Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 19, 2019 |
| Last Updated Date: | Apr 13, 2020 |
| Original Closing Date for Applications: | Apr 01, 2020 |
| Current Closing Date for Applications: | Jul 01, 2020 |
| Archive Date: | Jul 31, 2020 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts City or township governments Public housing authorities/Indian housing authorities Special district governments State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments For profit organizations other than small businesses Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to support the development of novel therapeutics which are directed to intracellular HIV targets. During the HIV life cycle multiple viral associated proteins are expressed in the infected cell. All are critical to support assembly, release and maturation of the virus. Considering each protein has a defined role in the life cycle, therapeutically targeting one or more may be an effective strategy to obtain potent antiviral activity. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-072.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Close date has been extended | Apr 13, 2020 | |
| Dec 19, 2019 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-19-072 |
| Funding Opportunity Title: | Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 19, 2019 |
| Last Updated Date: | Apr 13, 2020 |
| Original Closing Date for Applications: | Apr 01, 2020 |
| Current Closing Date for Applications: | Jul 01, 2020 |
| Archive Date: | Jul 31, 2020 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts City or township governments Public housing authorities/Indian housing authorities Special district governments State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments For profit organizations other than small businesses Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to support the development of novel therapeutics which are directed to intracellular HIV targets. During the HIV life cycle multiple viral associated proteins are expressed in the infected cell. All are critical to support assembly, release and maturation of the virus. Considering each protein has a defined role in the life cycle, therapeutically targeting one or more may be an effective strategy to obtain potent antiviral activity. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-072.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-19-072 |
| Funding Opportunity Title: | Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 19, 2019 |
| Last Updated Date: | Dec 19, 2019 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 01, 2020 |
| Archive Date: | May 07, 2020 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Small businesses State governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments Independent school districts City or township governments Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support the development of novel therapeutics which are directed to intracellular HIV targets. During the HIV life cycle multiple viral associated proteins are expressed in the infected cell. All are critical to support assembly, release and maturation of the virus. Considering each protein has a defined role in the life cycle, therapeutically targeting one or more may be an effective strategy to obtain potent antiviral activity. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-072.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259736 | Mar 02, 2020 | Apr 01, 2020 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00257227 | Mar 02, 2020 | Jul 01, 2020 | View |
Package 1
Mandatory forms
323183 RR_SF424_2_0-2.0.pdf
323183 PHS398_CoverPageSupplement_5_0-5.0.pdf
323183 RR_OtherProjectInfo_1_4-1.4.pdf
323183 PerformanceSite_2_0-2.0.pdf
323183 RR_KeyPersonExpanded_2_0-2.0.pdf
323183 PHS398_ResearchPlan_4_0-4.0.pdf
323183 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
323183 RR_Budget_1_4-1.4.pdf
323183 RR_SubawardBudget30_1_4-1.4.pdf
323183 PHS398_ModularBudget_1_2-1.2.pdf
323183 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
323183 RR_SF424_2_0-2.0.pdf
323183 PHS398_CoverPageSupplement_4_0-4.0.pdf
323183 RR_OtherProjectInfo_1_4-1.4.pdf
323183 PerformanceSite_2_0-2.0.pdf
323183 RR_KeyPersonExpanded_2_0-2.0.pdf
323183 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
323183 RR_Budget_1_4-1.4.pdf
323183 RR_SubawardBudget30_1_4-1.4.pdf
323183 PHS398_ModularBudget_1_2-1.2.pdf
323183 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
